Cargando…
Analysis of α-synuclein levels related to LRRK2 kinase activity: from substantia nigra to urine of patients with Parkinson’s disease
Research on Parkinson’s disease (PD) has been focused on the development of PD diagnostic tools as much as the development of PD therapeutics. Several genetic culprits of PD, including DJ-1, Leucine-rich repeat kinase 2 (LRRK2), and α-synuclein (α-syn), have been investigated as markers of PD in hum...
Autores principales: | Nam, Daleum, Kim, Ami, Han, Sun Jung, Lee, Sung-Ik, Park, Sung-Hye, Seol, Wongi, Son, Ilhong, Ho, Dong Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935126/ https://www.ncbi.nlm.nih.gov/pubmed/33717414 http://dx.doi.org/10.1080/19768354.2021.1883735 |
Ejemplares similares
-
Rab GTPases as Physiological Substrates of LRRK2 Kinase
por: Seol, Wongi, et al.
Publicado: (2019) -
LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss
por: Ho, Dong-Hwan, et al.
Publicado: (2022) -
The Changes of Mitochondria in Substantia Nigra and Anterior Cerebral Cortex of Hepatic Encephalopathy Induced by Thioacetamide
por: Bai, Yunhu, et al.
Publicado: (2019) -
LRRK2 Kinase Inhibitor Rejuvenates Oxidative Stress-Induced Cellular Senescence in Neuronal Cells
por: Ho, Dong Hwan, et al.
Publicado: (2021) -
Dexamethasone induces the expression of LRRK2 and α-synuclein, two genes that when mutated cause Parkinson’s disease in an autosomal dominant manner
por: Park, Ji-Min, et al.
Publicado: (2013)